TNXP – tonix pharmaceuticals holding corp. (US:NASDAQ)
Stock Stats
News
Muscarinic Acetylcholine Receptor M1 Antagonists Pipeline Research Report 2024: Comprehensive Insights on 8+ Drugs Featuring Tonix Pharmaceuticals, BMS, WinSanTor, and Apnimed [Yahoo! Finance]
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting [Yahoo! Finance]
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting
Form SC 13G/A Tonix Pharmaceuticals Filed by: ARMISTICE CAPITAL, LLC
Form SC 13G/A Tonix Pharmaceuticals Filed by: Alyeska Investment Group, L.P.
Form 8-K Tonix Pharmaceuticals For: Nov 13
Form 10-Q Tonix Pharmaceuticals For: Sep 30
Form 8-K Tonix Pharmaceuticals For: Nov 12
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.